[Hypercalcemia as a complication in the hormonal treatment of carcinoma of the breast with metastases and the hormone activity of tumors].
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D002116:Calcitonin / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000378:metabolism; D004921:Erythropoietin / Q000378:metabolism; D004958:Estradiol / Q000009:adverse effects*; D005260:Female; D005755:Gastrins / Q000378:metabolism; D006729:Hormones, Ectopic; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009384:Paraneoplastic Endocrine Syndromes; D010281:Parathyroid Hormone / Q000096:biosynthesis*; D011374:Progesterone / Q000009:adverse effects*
D006063:Chorionic Gonadotropin; D005755:Gastrins; D006729:Hormones, Ectopic; D010281:Parathyroid Hormone; D004921:Erythropoietin; D011374:Progesterone; D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D002116:Calcitonin; D006916:5-Hydroxytryptophan
Hyperkalzämie als Komplikation bei der Hormonbehandlung des metasierenden Mama-Karzinoms und Hormonaktivität von Tumoren.